✦ LIBER ✦

One failed clinical trial (of 5HT3 antagonists) does not invalidate the concept

✍ Scribed by Matti Förster; Ralf Baron

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The 5-HT3antagonist, BRL 43694, does not

✍ Phyllis M. Goddard; Mervyn Jones; Linda A. Pollard; Melanie R. Valenti; Kenneth 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 244 KB

A dose-ranging, placebo-controlled, rand

✍ George E Dukes; Nicolas J Talley; Sander V van Zanten; Mark Heath; Susan C Sorre 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 33 KB

5-HT3 receptor antagonists fail to block

✍ Kurt Batsche; Martin I. Granoff; Rex Y. Wang 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 517 KB

ChemInform Abstract: New Benzamide-Deriv

✍ G. IUSCO; V. BOIDO; F. SPARATORE; G. COLOMBO; P. L. SABA; Z. ROSSETTI; A. VACCAR 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 29 KB 👁 2 views

Combined data from two phase III trials

✍ P. J. Hesketh; S. M. Grunberg; J. Herrstedt; R. de Wit; R. J. Gralla; A. D. Cari 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 124 KB

Antiemetic efficacy of the neurokinin-1

✍ Richard J. Gralla; Ronald de Wit; Jorn Herrstedt; Alexandra D. Carides; Juliana 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB